rs553784643
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_006514.4(SCN10A):c.1715C>T(p.Pro572Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000318 in 1,571,836 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_006514.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN10A | NM_006514.4 | c.1715C>T | p.Pro572Leu | missense_variant | 12/28 | ENST00000449082.3 | NP_006505.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN10A | ENST00000449082.3 | c.1715C>T | p.Pro572Leu | missense_variant | 12/28 | 1 | NM_006514.4 | ENSP00000390600 | P4 | |
SCN10A | ENST00000655275.1 | c.1742C>T | p.Pro581Leu | missense_variant | 12/28 | ENSP00000499510 | ||||
SCN10A | ENST00000643924.1 | c.1715C>T | p.Pro572Leu | missense_variant | 11/27 | ENSP00000495595 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000264 AC: 4AN: 151802Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000593 AC: 13AN: 219102Hom.: 0 AF XY: 0.0000422 AC XY: 5AN XY: 118420
GnomAD4 exome AF: 0.0000324 AC: 46AN: 1419916Hom.: 0 Cov.: 30 AF XY: 0.0000256 AC XY: 18AN XY: 703760
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151920Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74226
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jun 04, 2018 | A variant of uncertain significance has been identified in the SCN10A gene. The P572L variant has not been published as pathogenic or been reported as benign to our knowledge. It is classified as a variant of uncertain significance in ClinVar by another clinical laboratory (SCV000547178.2; Landrum et al., 2016). This variant is observed at a global allele frequency of 13/214918 (0.006%) alleles in large population cohorts, including 4/14804 (0.03%) alleles from individuals of East Asian ancestry (Lek et al., 2016). The P572L variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. However, in-silico analyses, including protein predictors and evolutionary conservation, support that this variant does not alter protein structure/function. - |
Brugada syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 13, 2022 | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 572 of the SCN10A protein (p.Pro572Leu). This variant is present in population databases (rs553784643, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with SCN10A-related conditions. ClinVar contains an entry for this variant (Variation ID: 407749). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SCN10A protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 09, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at